TrialClinical drug investigation2019

Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts.

Eriko Sumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.